# Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/durability-and-tolerability-of-dapagliflozin-over-52-weeks-as-add-on-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | S. Matthäei,Keith Bowering,Katja Rohwedder,Jennifer Sugg,Shamik Parikh,Eva Johnsson,on behalf of the Study 05 Group |
| Citations | 69 |
| DOI | 10.1111/dom.12543 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1953794210 |
| PMID | 26212528 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Katja Rohwedder](https://scholariq.org/researchers/katja-rohwedder/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.